Company Profile
Beijing Aosaikang Pharmaceutical researches, develops, produces, and sells active pharmaceutical ingredients and formulations in China. It also offers digestive health products, which include pump inhibitors suitable for various digestive tract-related diseases, such as peptic ulcers, reflux esophagitis, and upper gastrointestinal bleeding anti-tumor products, including the treatment of non-small cell lung cancer, colorectal cancer, and breast cancer, encompassing targeted therapy, chemotherapy, endocrine therapy, and adjuvant medications
Anti-infective products comprising a product defense line against bacterial and invasive fungal infections The chronic disease field focusing on chronic diseases requiring long-term management consisting of diabetes, osteoarthritis, thrombocytopenia, and iron overload. Founded in 1996, Beijing Aosaikang Pharmaceutical is based in Nanjing, China.